For people with chronic skin conditions, telehealth altered how they care for their skin and their bodies by removing ...

ADBRY ® (tralokinumab) 12‑month real‑world data from the TRACE study evaluating the safety and effectiveness of AD ...

Annual Meeting, James Song, MD, chief medical officer and director of clinical research, Frontier Dermatology, outlines maj ...

Do *not* scratch it.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...

(Kinga Krzeminska/Moment/Getty Images) It's been known for some time that psychological stress can make eczema (atopic ...

Wendy Smith Begolka, MBS, shares strategies to better meet the needs of patients with chronic inflammatory skin diseases.

MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-controlled ...

Salt rooms regenerate health skin cells and boost our breathing. Here's what to look for when finding a salt room experience.

Traditional dermatology is only beginning to fully address the connection between the gut and our skin for too long.

Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 19, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results ...

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the best growth stocks to buy right now. On March 10, Arcutis Biotherapeutics announced the publication of long-term Phase 3 data regarding ZORYVE ...